The 'biodrug' concept: an innovative approach to therapy (Q34392306)

1 August 2017

1 reference

title

The 'biodrug' concept: an innovative approach to therapy (English)

1 reference

1 August 2017

Blanquet S

1

1 reference

1 August 2017

Marol-Bonnin S

2

1 reference

1 August 2017

Beyssac E

3

1 reference

1 August 2017

Pompon D

4

1 reference

1 August 2017

Renaud M

5

1 reference

1 August 2017

Alric M

6

1 reference

1 August 2017

publication date

1 October 2001

1 reference

1 August 2017

published in

Trends in Biotechnology

1 reference

1 August 2017

volume

19

1 reference

1 August 2017

issue

10

1 reference

1 August 2017

page(s)

393-400

1 reference

The application of genetically engineered micro-organisms in the production of drugs

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2801%2901739-5

7 January 2021

Therapeutic uses of microencapsulated genetically engineered cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2801%2901739-5

7 January 2021

Saccharomyces boulardii'. A Review of an Innovative Biotherapeutic Agent

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2801%2901739-5

7 January 2021

Environmental potential of suicide genes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2801%2901739-5

7 January 2021

Controlled overproduction of proteins by lactic acid bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2801%2901739-5

7 January 2021

The complete genome sequence of the lactic acid bacterium Lactococcus lactis ssp. lactis IL1403

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2801%2901739-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0167-7799%2801%2901739-5

1 reference

7 January 2021

Simulation of human xenobiotic metabolism in microorganisms. Yeast a good compromise between E. coli and human cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2801%2901739-5

7 January 2021

Self-sufficient biosynthesis of pregnenolone and progesterone in engineered yeast

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2801%2901739-5

7 January 2021

Strategies for the genetic manipulation of Saccharomyces cerevisiae

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2801%2901739-5

7 January 2021

Survival, physiology, and lysis of Lactococcus lactis in the digestive tract

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2801%2901739-5

7 January 2021

Digestion and absorption of food: usefulness and limitations of in vitro models

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2801%2901739-5

7 January 2021

Critical evaluation of in vitro methods for estimating digestibility in simple-stomach animals

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2801%2901739-5

7 January 2021

A computer-controlled system to simulate conditions of the large intestine with peristaltic mixing, water absorption and absorption of fermentation products

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2801%2901739-5

7 January 2021

Survival of lactic acid bacteria in a dynamic model of the stomach and small intestine: validation and the effects of bile

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2801%2901739-5

7 January 2021

Characterization of recombinant plant cinnamate 4-hydroxylase produced in yeast. Kinetic and spectral properties of the major plant P450 of the phenylpropanoid pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2801%2901739-5

7 January 2021

In vitro and in vivo uric acid lowering by artificial cells containing microencapsulated genetically engineered E. coli DH5 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2801%2901739-5

7 January 2021

Expression of the protective antigen of Bacillus anthracis by Lactobacillus casei: towards the development of an oral vaccine against anthrax.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2801%2901739-5

7 January 2021

Oral vaccination of mice against tetanus with recombinant Lactococcus lactis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2801%2901739-5

7 January 2021

Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2801%2901739-5

7 January 2021

Proportion of the GSTM1 0/0 genotype in some Slavic populations and its correlation with cystic fibrosis and some multifactorial diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2801%2901739-5

7 January 2021

Lactic acid bacteria as antigen delivery vehicles for oral immunization purposes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2801%2901739-5

7 January 2021

Yeast expressing hepatitis B virus surface antigen determinants on its surface: implications for a possible oral vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2801%2901739-5

7 January 2021

Protein glycosylation in yeast

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2801%2901739-5

7 January 2021

Kinetics of Saccharomyces cerevisiae elimination from the intestines of human volunteers and effect of this yeast on resistance to microbial colonization in gnotobiotic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2801%2901739-5

7 January 2021

Probiotics: determinants of survival and growth in the gut.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2801%2901739-5

7 January 2021

10.1016/S0167-7799(01)01739-5

Identifiers

DOI

1 reference

1 August 2017

1 reference